Literature DB >> 24134485

Cavernoma-related epilepsy: review and recommendations for management--report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies.

Felix Rosenow1, Mario A Alonso-Vanegas, Christoph Baumgartner, Ingmar Blümcke, Maria Carreño, Elke R Gizewski, Hajo M Hamer, Susanne Knake, Philippe Kahane, Hans O Lüders, Gary W Mathern, Katja Menzler, Jonathan Miller, Taisuke Otsuki, Cigdem Ozkara, Asla Pitkänen, Steven N Roper, Americo C Sakamoto, Ulrich Sure, Matthew C Walker, Bernhard J Steinhoff.   

Abstract

Cerebral cavernous malformations (CCMs) are well-defined, mostly singular lesions present in 0.4-0.9% of the population. Epileptic seizures are the most frequent symptom in patients with CCMs and have a great impact on social function and quality of life. However, patients with CCM-related epilepsy (CRE) who undergo surgical resection achieve postoperative seizure freedom in only about 75% of cases. This is frequently because insufficient efforts are made to adequately define and resect the epileptogenic zone. The Surgical Task Force of the Commission on Therapeutics of the International League Against Epilepsy (ILAE) and invited experts reviewed the pertinent literature on CRE. Definitions of definitive and probable CRE are suggested, and recommendations regarding the diagnostic evaluation and etiology-specific management of patients with CRE are made. Prospective trials are needed to determine when and how surgery should be done and to define the relations of the hemosiderin rim to the epileptogenic zone. Wiley Periodicals, Inc.
© 2013 International League Against Epilepsy.

Entities:  

Keywords:  Cavernous hemangioma; Epilepsy surgery; Etiology; Outcome; Risk factors

Mesh:

Substances:

Year:  2013        PMID: 24134485     DOI: 10.1111/epi.12402

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  25 in total

1.  Prospective Hemorrhage Rates of Cerebral Cavernous Malformations in Children and Adolescents Based on MRI Appearance.

Authors:  O Nikoubashman; F Di Rocco; I Davagnanam; K Mankad; M Zerah; M Wiesmann
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-13       Impact factor: 3.825

Review 2.  Cavernous angiomas: deconstructing a neurosurgical disease.

Authors:  Issam A Awad; Sean P Polster
Journal:  J Neurosurg       Date:  2019-07-01       Impact factor: 5.115

3.  [Intracranial vascular malformations].

Authors:  D F Vollherbst; M Bendszus; M A Möhlenbruch
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

Review 4.  Should we resect peri-lesional hemosiderin deposits when performing lesionectomy in patients with cavernoma-related epilepsy (CRE)?

Authors:  P Dammann; C Schaller; U Sure
Journal:  Neurosurg Rev       Date:  2016-11-08       Impact factor: 3.042

Review 5.  Emerging Use of Ultra-High-Field 7T MRI in the Study of Intracranial Vascularity: State of the Field and Future Directions.

Authors:  J W Rutland; B N Delman; C M Gill; C Zhu; R K Shrivastava; P Balchandani
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-26       Impact factor: 3.825

6.  Safety and effectiveness of stereotactic laser ablation for epileptogenic cerebral cavernous malformations.

Authors:  Jon T Willie; James G Malcolm; Matthew A Stern; Lindsay O Lowder; Stewart G Neill; Brian T Cabaniss; Daniel L Drane; Robert E Gross
Journal:  Epilepsia       Date:  2019-01-17       Impact factor: 5.864

Review 7.  Clinical Management of Cavernous Malformations.

Authors:  Kelly D Flemming
Journal:  Curr Cardiol Rep       Date:  2017-10-18       Impact factor: 2.931

Review 8.  Familial Cerebral Cavernous Malformations.

Authors:  Atif Zafar; Syed A Quadri; Mudassir Farooqui; Asad Ikram; Myranda Robinson; Blaine L Hart; Marc C Mabray; Catherine Vigil; Alan T Tang; Mark L Kahn; Howard Yonas; Michael T Lawton; Helen Kim; Leslie Morrison
Journal:  Stroke       Date:  2019-05       Impact factor: 7.914

9.  Cavernous malformations of the central nervous system (CNS) in children: clinico-radiological features and management outcomes of 36 cases.

Authors:  Burcak Bilginer; Firat Narin; Sahin Hanalioglu; Kader Karlı Oguz; Figen Soylemezoglu; Nejat Akalan
Journal:  Childs Nerv Syst       Date:  2014-05-31       Impact factor: 1.475

10.  Magnetic Resonance Thermometry-Guided Stereotactic Laser Ablation of Cavernous Malformations in Drug-Resistant Epilepsy: Imaging and Clinical Results.

Authors:  D Jay McCracken; Jon T Willie; Brad A Fernald; Amit M Saindane; Daniel L Drane; Daniel L Barrow; Robert E Gross
Journal:  Oper Neurosurg (Hagerstown)       Date:  2015-09-25       Impact factor: 2.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.